Table: Ono Pharm -9-MTH group results (IFRS)

ONO PHARMACEUTICAL

31/01/2020 03:00

Jan 31 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2019        Dec 31, 2018     Mar 31, 2020 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              225.30              223.20           290.00    
                   (+0.9 pct)          (+11.3 pct)      (+0.5 pct)  
  Operating           66.05               52.15            71.00    
                   (+26.7 pct)         (-0.1 pct)       (+14.5 pct) 
  Pretax              68.69               55.23            73.00    
                   (+24.4 pct)         (-0.2 pct)       (+12.1 pct) 
  Net                 51.83               43.13            55.00    
                   (+20.2 pct)         (+4.1 pct)       (+6.7 pct)  
  EPS Basic        102.54 yen           83.90 yen       108.82 yen  
  EPS Diluted      102.53 yen           83.89 yen                   
  Ann Div                               45.00 yen        45.00 yen  
  -Q2 Div           22.50 yen           22.50 yen                   
  -Q4 Div                               22.50 yen        22.50 yen  
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T